17 February 2010
Nancy Faigen
Merck & Co has agreed to pay up $12.5 million in plaintiffs' legal fees to settle shareholder "derivative" suits in US state and federal courts that allege breach of financial duties by senior executives over the withdrawn painkiller Vioxx (rofecoxib).
As part of the settlement,...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
